4//SEC Filing
Morris Arlene 4
Accession 0000950170-23-028721
CIK 0001590750other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 7:51 PM ET
Size
5.5 KB
Accession
0000950170-23-028721
Insider Transaction Report
Form 4
Morris Arlene
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-14+20,000→ 20,000 totalExercise: $27.67Exp: 2033-06-14→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The option vests in full upon the earlier to occur of (i) June 14, 2024 or (ii) the Issuer's 2024 annual meeting of stockholders, subject to Reporting Person's continued service on the Board.
Documents
Issuer
Viridian Therapeutics, Inc.\DE
CIK 0001590750
Entity typeother
Related Parties
1- filerCIK 0001362520
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 7:51 PM ET
- Size
- 5.5 KB